1088 related articles for article (PubMed ID: 29341269)
21. The difference in gliosis induced by β-amyloid and Tau treatments in astrocyte cultures derived from senescence accelerated and normal mouse strains.
Lü L; Mak YT; Fang M; Yew DT
Biogerontology; 2009 Dec; 10(6):695-710. PubMed ID: 19221889
[TBL] [Abstract][Full Text] [Related]
22. Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease.
Romano A; Pace L; Tempesta B; Lavecchia AM; Macheda T; Bedse G; Petrella A; Cifani C; Serviddio G; Vendemiale G; Gaetani S; Cassano T
Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25609597
[TBL] [Abstract][Full Text] [Related]
23. 3×Tg-AD Mice Overexpressing Phospholipid Transfer Protein Improves Cognition Through Decreasing Amyloid-β Production and Tau Hyperphosphorylation.
Wang WZ; Li MW; Chen Y; Liu LY; Xu Y; Xia ZH; Yu Y; Wang XD; Chen W; Zhang F; Xu XY; Gao YF; Zhang JG; Qin SC; Wang H
J Alzheimers Dis; 2021; 82(4):1635-1649. PubMed ID: 34219730
[TBL] [Abstract][Full Text] [Related]
24. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
25. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
[TBL] [Abstract][Full Text] [Related]
26. Evidence for altered Numb isoform levels in Alzheimer's disease patients and a triple transgenic mouse model.
Chigurupati S; Madan M; Okun E; Wei Z; Pattisapu JV; Mughal MR; Mattson MP; Chan SL
J Alzheimers Dis; 2011; 24(2):349-61. PubMed ID: 21258150
[TBL] [Abstract][Full Text] [Related]
27. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
[TBL] [Abstract][Full Text] [Related]
28. Early-in-life neuroanatomical and behavioural trajectories in a triple transgenic model of Alzheimer's disease.
Kong V; Devenyi GA; Gallino D; Ayranci G; Germann J; Rollins C; Chakravarty MM
Brain Struct Funct; 2018 Sep; 223(7):3365-3382. PubMed ID: 29948190
[TBL] [Abstract][Full Text] [Related]
29. Postsynaptic Protein Shank3a Deficiency Synergizes with Alzheimer's Disease Neuropathology to Impair Cognitive Performance in the 3xTg-AD Murine Model.
Landry O; François A; Oye Mintsa Mi-Mba MF; Traversy MT; Tremblay C; Emond V; Bennett DA; Gylys KH; Buxbaum JD; Calon F
J Neurosci; 2023 Jun; 43(26):4941-4954. PubMed ID: 37253603
[TBL] [Abstract][Full Text] [Related]
30. The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Niehoff ML; Morley JE; Jelsing J; Pyke C; Knudsen LB; Farr SA; Vrang N
J Alzheimers Dis; 2015; 46(4):877-88. PubMed ID: 25869785
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of the pore-forming K
Griffith CM; Xie MX; Qiu WY; Sharp AA; Ma C; Pan A; Yan XX; Patrylo PR
Neuroscience; 2016 Nov; 336():81-101. PubMed ID: 27586053
[TBL] [Abstract][Full Text] [Related]
32. High Levels of
Piccarducci R; Pietrobono D; Pellegrini C; Daniele S; Fornai M; Antonioli L; Trincavelli ML; Blandizzi C; Martini C
Oxid Med Cell Longev; 2019; 2019():5030475. PubMed ID: 31281579
[TBL] [Abstract][Full Text] [Related]
33. Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer's disease.
Vandal M; White PJ; Chevrier G; Tremblay C; St-Amour I; Planel E; Marette A; Calon F
FASEB J; 2015 Oct; 29(10):4273-84. PubMed ID: 26108977
[TBL] [Abstract][Full Text] [Related]
34. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
Tapia-Rojas C; Aranguiz F; Varela-Nallar L; Inestrosa NC
Brain Pathol; 2016 Jan; 26(1):62-74. PubMed ID: 25763997
[TBL] [Abstract][Full Text] [Related]
35. Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer disease.
Giménez-Llort L; Rivera-Hernández G; Marin-Argany M; Sánchez-Quesada JL; Villegas S
MAbs; 2013; 5(5):665-77. PubMed ID: 23884018
[TBL] [Abstract][Full Text] [Related]
36. Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer's disease.
St-Amour I; Bosoi CR; Paré I; Ignatius Arokia Doss PM; Rangachari M; Hébert SS; Bazin R; Calon F
J Neuroinflammation; 2019 Jan; 16(1):3. PubMed ID: 30611289
[TBL] [Abstract][Full Text] [Related]
37. Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice.
Clark JK; Furgerson M; Crystal JD; Fechheimer M; Furukawa R; Wagner JJ
Neurobiol Learn Mem; 2015 Nov; 125():152-162. PubMed ID: 26385257
[TBL] [Abstract][Full Text] [Related]
38. Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles.
Di Meco A; Joshi YB; Praticò D
Neurobiol Aging; 2014 Aug; 35(8):1813-20. PubMed ID: 24629673
[TBL] [Abstract][Full Text] [Related]
39. Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease.
Beggiato S; Cassano T; Ferraro L; Tomasini MC
Life Sci; 2020 Sep; 257():118037. PubMed ID: 32622942
[TBL] [Abstract][Full Text] [Related]
40. Age and sex differences in motivation and spatial working memory in 3xTg-AD mice in the Hebb-Williams maze.
Fertan E; Wong AA; Vienneau NA; Brown RE
Behav Brain Res; 2019 Sep; 370():111937. PubMed ID: 31121220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
